Latest Cancer News

Neratinib Improves Cancer-Free Survival in Early Breast Cancer (07-27-2016)
The targeted agent neratinib (PB272), which is still in clinical trials, demonstrated an improvement in cancer-free survival when used after Herceptin® (trastuzumab) in early-stage, HER2-positive breast... Continue Reading

Cabozantinib Does Not Demonstrate Improvements in Advanced Prostate Cancer (07-26-2016)
In a recent study, the targeted agent cabozantinib did not demonstrate an improvement in outcomes compared to prednisone, among men with advanced prostate cancer. These results were recently published... Continue Reading

3-Year Survival Improved with Taflinar®/Mekinist® Combination in Advanced Melanoma (07-21-2016)
Patients with advanced melanoma who were treated with the combination consisting of Taflinar (dabrafenib) plus Mekinist (trametinib) had a significantly improved survival rate at 3 years compared to those... Continue Reading

More Cancer News

Locations

Jackson
322 Hospital Boulevard
Jackson, TN 38305
731-668-1668
800-870-5471
Dyersburg
440 Wilkinson Drive
Dyersburg, TN 38024
731 285-2211
888-748-8511
Paris
1290 Kelley Drive
Paris, TN 38242
731-644-3522
800-221-0948
Union City
1209 Reelfoot Ave.
Union City, TN 38261
731-884-8611
888-941-8611